Mariusz Tomaniak

Mariusz Tomaniak

Interventional cardiologist / Cardiologist
Medical University of Warsaw - Warsaw, Poland

Latest contributions

Road to relief - Effective treatment of refractory angina patients with Shockwave Reducer

22 May 2025 – From EuroPCR 2025

Refractory angina affects more than 100 million people globally and is associated with a significantly increased risk of adverse cardiovascular events. Treating this condition effectively remains a major clinical challenge. This session provides detailed insights into the use of the Shockwave Reducer device as an innovative therapeutic...

Road to relief - Effective treatment of refractory angina patients with Shockwave Reducer

Antithrombotic drugs for acute coronary syndromes in women

21 May 2025 – From EuroPCR 2025

Enhance your understanding of antithrombotic drug management in women with acute coronary syndromes (ACS). This session addresses risk stratification balancing ischemic and bleeding risks, evidence-based tailored antithrombotic and revascularisation strategies in high bleeding risk patients, and diagnostic and treatment approaches for MINOCA, with illustrative cases highlighting...

Antithrombotic drugs for acute coronary syndromes in women

Invasive treatment of refractory angina

20 May 2025 – From EuroPCR 2025

Explore invasive treatment options for refractory angina through clinical case presentations emphasizing coronary physiology guidance, coronary microvascular disease management, and innovative therapies such as coronary sinus reducer implantation. This session highlights provocative test-guided approaches to optimize patient outcomes.

Invasive treatment of refractory angina

It's not all about the anatomy - When physiology matters!

14 May 2024 – From EuroPCR 2024

This session, in collaboration with various international cardiology societies, emphasizes the importance of physiology-guided interventions in complex multivessel disease. It presents three cases demonstrating the use of CTCA-derived cFFR, pressure wire assessment in bifurcation PCI, and angio-based FFR to guide treatment decisions. The discussions highlight how...

It's not all about the anatomy - When physiology matters!

Vulnerable plaques and vulnerable patients

27 Jun 2020 – From PCR e-Course 2020

Watch this session to learn more about latest advances in detecting and treating vulnerable plaques and patients, in predicting clinical events, and the imaging options for prevention and treatment.

This session was originally presented during PCR e-Course 2020.

Vulnerable plaques and vulnerable patients

New approaches in the functional assessment of coronary stenosis

22 May 2019 – From EuroPCR 2019

Consult this session to learn all about the new approaches in the functional assessment of coronary stenosis, such as the Quantitative Flow Ratio, the FAST EXTEND study, and more!

New approaches in the functional assessment of coronary stenosis

Pharmacotherapy before/during/after PCI

21 May 2019 – From EuroPCR 2019

Consult this session to learn all about pharmacotherapy before / during / after PCI, and discover the results of various studies and trials: GLOBAL LEADERS, DUAL PCI, MATRIX, and more!

Pharmacotherapy before/during/after PCI

Obstructive and non-obstructive coronary disease in women

21 May 2019 – From EuroPCR 2019

Consult this session on obstructive and non-obstructive coronary disease in women to learn how to diagnose and manage non-obstructive coronary artery disease in women, thanks to a better understanding of gender-related aspects of coronary artery disease and responses to antiplatelet therapies.

Obstructive and non-obstructive coronary disease in women